SIGN IN
Email Address
Password

Forgot password?
REGISTER HERE >>

Oncology Courses from Johns Hopkins


Sponsored by the Johns Hopkins University School of Medicine, these activities focus on the latest developments in the treatment of various cancers. 






Non-Small Cell Lung Cancer Management based on EGFR Mutation Status

1.00 / AMA PRA Category 1 Credit(s)TM
Lung cancer is a major cause of cancer death worldwide, largely because most patients have advanced-stage disease at the time of diagnosis. Epidermal growth factor receptor (EGFR) has surfaced as an important target for therapy in different solid tumors, including non-small cell lung cancer (NSCLC).
 

Colorectal Cancer and Evidence for Cure by Adjuvant Chemotherapy

1.00 / AMA PRA Category 1 Credit(s)TM
Although the combination of 5-FU/leucovorin (LV) and oxaliplatin has since become the standard of care for adjuvant therapy in colorectal cancer, analyses from the trials in the ACCENT database continue to provide valuable information on the course of the disease after adjuvant therapy.
 

Oncofertility in Clinical Practice

1.00 / AMA PRA Category 1 Credit(s)TM
Improved cancer survival rates have created unique challenges for clinicians caring for young oncology patients. This activity, sponsored by the Johns Hopkins University School of Medicine, will review the fertility preservation options available to young cancer patients.
 

Evidence for the Use of Circulating Tumor Cells in the Prognostic Stratification of Women with Metastatic Breast Cancer

1.00 / AMA PRA Category 1 Credit(s)TM
Despite significant advances in the field of oncology, metastatic breast cancer (MBC) still remains among the leading causes of death for women.
 

Carcinoma of Unknown Primary:
Changing Paradigm in the Era of Molecular Profiling

1.00 / AMA PRA Category 1 Credit(s)TM
Carcinoma of unknown primary (CUP) is the presence of metastatic cancer in the absence of a primary tumor after a thorough clinical, radiologic, and pathologic review.
 

MRI Identifies Secondary Breast Cancers in Patients Eligible for Partial Breast Irradiation

1.00 / AMA PRA Category 1 Credit(s)TM
Partial breast irradiation (PBI) techniques are being investigated for low-risk breast cancer patients. This activity will compare the results of MRI and standard screening and evaluate whether the use of MRI should alter eligibility for PBI.
 

Efficacy and Safety of Everolimus Treatment in Metastatic Renal Cell Carcinoma

1.00 / AMA PRA Category 1 Credit(s)TM
Recently, small-molecule targeted inhibitors of vascular endothelial growth factor have demonstrated antitumor activity in randomized phase III clinical trials and have been incorporated into standard disease management. This activity reviews efficacy results from the phase III study involving treatment of metastatic renal cell carcinoma.
 

Adjuvant Chemotherapy and Radiation following PDD for Pancreatic Adenocarcinoma: Summary of Trials and Future Directions

1.00 / AMA PRA Category 1 Credit(s)TM
This activity identifies trials that have investigated the use of adjuvant chemotherapy and radiation following pancreaticoduodenectomy and assesses results from the trials summarized.
 

Survival after High-Dose Therapy and Autologous Transplantation in Chemoresistant HL

1.00 / AMA PRA Category 1 Credit(s)TM
Despite cure in the majority of Hodgkin lymphoma patients, relapsed and refractory disease can occur. This activity reviews the treatment modalities available to patients with chemoresistant Hodgkin lymphoma, and summarizes the possible reasons for improved outcomes.
 

Lack of Clarity around Physician Roles during Cancer Survivorship Care Planning

1.00 / AMA PRA Category 1 Credit(s)TM
Many cancer patients diagnosed today will become long-term cancer survivors, a consequence of progress made in early detection and treatment strategies. Despite surviving their primary cancer, however, these individuals often continue to experience ongoing medical issues.
 

Clinical Benefits and Costs of New Treatments for Advanced Colorectal Cancer

1.00 / AMA PRA Category 1 Credit(s)TM
Colorectal cancer (CRC) is the second leading cause of cancer mortality in the United States and is expected to result in more than 49 000 deaths in 2009. Until the mid-1990s, the only active agent for CRC was 5-fluorouracil (5-FU). Despite biomodulation with leucovorin, response rates were modest and survival ...
 

Johns Hopkins University School of Medicine Cardiovascular & Cardiometabolic Disease Webcast Series


Cardiovascular & Cardiometabolic disorders are the leading cause of death in the US, primarily due to the effects of heart disease and stroke. Nearly 2,300 Americans die of CVD every day, including a substantial number of individuals who are less than 65 years of age. This webcast series is designed to help clinicians improve their ability to diagnose, manage, and treat cardiovascular and metabolic disorders. Each activity features a moderated case discussion with faculty from the Johns Hopkins Division of Cardiology, a world-renowned center for every aspect of cardiovascular care and research. The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Copyright
All rights reserved - The Johns Hopkins University School of Medicine.

NEW DRUG CME FROM MPR

New Drug Approvals

     
    Exclusively from myCME.com and the editors of MPR. 
     
  • Learn about the newest drug approvals and uses while earning CME/CE credit

CHECK OUT THE FORUM

Clinicians who provide care for reproductive-aged and menopausal women are faced with continual change that affects the way in which they practice. This multi-part series looks at issues such as celiac disease, cardiovascular disease, family planning, and osteoporotic fracture risk.

Click here for a full listing of all issues.

Acute Coronary Syndrome Journal Club for Primary Care

The value of the Acute Coronary Syndrome Journal Club resides in its ability to summarize and synthesize key scientific advances and clinical lessons from the literature, and offer commentary and insight from recognized experts in the field of treating ACS, who can explain the implications of the latest research findings and clinical trials for day-to-day patient care.

Click here for a full listing of activities.

Nursing Challenges in the Management of Acute Coronary Syndrome

This series, which includes a digital monograph and two related case studies, highlights current approaches to antiplatelet therapy for patients with acute coronary syndrome.

Click here for a full listing of activities.

Treatment Strategies for Acute Low Back Pain

This series, which includes a digital monograph and three related case studies, highlights the implications of generic substitution and the standards of care that pharmacists and clinicians must satisfy when engaging in generic substitution for the treatment of low back pain.

Click here for a full listing of activities.
Home | Browse By Disease | Browse By Specialty | Browse By Profession | About HME | Contact Us | Web Support

Your use of this website constitutes acceptance of Haymarket Medical Education's Privacy Policy and Terms & Conditions

Haymarket Medical Education